EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

[18F]flutemetamol uptake in the colon of a memory clinic population and its association with brain amyloidosis and the gut microbiota profile: an exploratory study

Giulia Quattrini, Elena Gatti, Débora Elisa Peretti, Marco Aiello, Claire Chevalier, Aurelien Lathuiliere, Rahel Park, Michela Pievani, Marco Salvatore, Max Scheffler, Annamaria Cattaneo, Giovanni B Frisoni und 2 weitere

European Journal of Nuclear Medicine and Molecular Imaging · 2025-10 · 52 (12) · 4591-4603

DOI: 10.1007/s00259-025-07299-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 02.05.2025. Verfasst von Giulia Quattrini und 13 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Alzheimer's Neuroimaging and Epidemiology (LANE), IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, 25125, Italy. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Colon, Benzothiazoles, Amyloidosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Ministero della Salute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Some Alzheimer’s disease (AD) patients report gastro-intestinal symptoms and present alterations in the gut microbiota (GM) composition. Elevated colonic amyloid immunoreactivity has been shown in patients and animal models. We evaluated the colonic uptake of the amyloid positron emission tomography (PET) imaging agent [18F]flutemetamol (FMM) in a memory clinic population and investigated its association with brain amyloidosis and GM composition.

Methods

Forty-five participants underwent (i) abdominal and cerebral FMM PET, acquired at 40 (early phase) and 120 min (late phase) after tracer injection, (ii) abdominal computed tomography, and (iii) cerebral T1-weighted MRI. Colonic standardized uptake value ratio (SUVr) was determined through manual tracing and automatic segmentation (TotalSegmentator), using the aortic blood signal as a reference region. Fecal GM composition was assessed using 16 S rRNA sequencing. Amyloid positive (A+) and negative (A-) participants, based on cortical FMM quantification (PetSurfer), were compared in terms of SUVr and GM features.

Results

Increased colonic early SUVr was reported in A+ than A- (manual, p =.008; automated, p =.035). Altered GM composition was found in A + as shown by lower Pielou’s evenness ( p =.023), lower abundance of Eubacterium hallii group , and higher abundance of several genera. High UC5-1-2E3 abundance positively correlated with high colonic early SUVr (whole group: manual, p =.012, automated, p =.082; A+: manual, p =.074; automated, p =.016).

Conclusion

This exploratory study showed that subjects with cerebral amyloidosis have greater colonic FMM uptake than subjects with normal cerebral amyloid load, correlating with altered GM composition. Further analysis is needed to determine if these changes denote amyloid-related changes or other phenomena.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeColonBenzothiazolesAmyloidosisAniline CompoundsMemoryHumansMaleFemaleAgedMiddle AgedBiological TransportPositron-Emission TomographyAlzheimer DiseaseAged, 80 and over

Stichwörter der Autor:innen

Alzheimer’s diseaseAmyloid PETColonGut microbiota

Substanzen

flutemetamolBenzothiazolesAniline Compounds

Autor:innen und Institutionen

  • Laboratory of Alzheimer's Neuroimaging and Epidemiology (LANE), IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, 25125, Italy.
  • Laboratory of Neuroimaging and Innovative Molecular Tracers, Geneva University Neurocenter and Faculty of Medicine, University of Geneva, Geneva, Switzerland.
  • IRCCS SYNLAB SDN, Naples, 80143, Italy.
  • Geneva Memory Center, Geneva University Hospitals, Geneva, Switzerland.
  • Laboratory of Neuroimaging of Aging (LANVIE), University of Geneva, Geneva, Switzerland.
  • Division of Radiology, Geneva University Hospitals, Geneva, Switzerland.

Förderung

  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
  • Ministero della Salute

Zitieren

APA

Quattrini, G., Gatti, E., Peretti, D. E., Aiello, M., Chevalier, C., Lathuiliere, A., Park, R., Pievani, M., Salvatore, M., Scheffler, M., Cattaneo, A., Frisoni, G. B., Garibotto, V., & Marizzoni, M. (2025). [18F]flutemetamol uptake in the colon of a memory clinic population and its association with brain amyloidosis and the gut microbiota profile: an exploratory study. European Journal of Nuclear Medicine and Molecular Imaging, 52(12), 4591-4603. https://doi.org/10.1007/s00259-025-07299-8

Vancouver

Quattrini G, Gatti E, Peretti DE, Aiello M, Chevalier C, Lathuiliere A, et al. [18F]flutemetamol uptake in the colon of a memory clinic population and its association with brain amyloidosis and the gut microbiota profile: an exploratory study. European Journal of Nuclear Medicine and Molecular Imaging. 2025;52(12):4591-4603. doi:10.1007/s00259-025-07299-8

BibTeX
@article{Quattrini2025,
  author = {Quattrini, Giulia and Gatti, Elena and Peretti, Débora Elisa and Aiello, Marco and Chevalier, Claire and Lathuiliere, Aurelien and Park, Rahel and Pievani, Michela and Salvatore, Marco and Scheffler, Max and Cattaneo, Annamaria and Frisoni, Giovanni B and Garibotto, Valentina and Marizzoni, Moira},
  title = {[18F]flutemetamol uptake in the colon of a memory clinic population and its association with brain amyloidosis and the gut microbiota profile: an exploratory study},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2025},
  volume = {52},
  number = {12},
  pages = {4591--4603},
  doi = {10.1007/s00259-025-07299-8}
}
Kostenlos starten →